Frontiers in Endocrinology· 2026Q1

RAGE signaling in acute myocardial infarction: sRAGE as a dynamic biomarker and emerging therapeutic target

Aneta Aleksova, Elena Vianello, Paola Primignani, Massimiliano M. Corsi Romanelli et al.

0citations
Q1SCImago
2026year

Short summary

Soluble RAGE (sRAGE) levels, a marker of RAGE pathway activity, are inconsistently associated with acute myocardial infarction (AMI) severity, but their dynamic changes over time may offer distinct prognostic information.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Clinical BiochemistryBiochemistry, Genetics and Molecular Biology